Overactive Bladder

Outcomes of a Single Trigone-Only vs. 20 Trigone-Sparing Injections of OnabotulinumtoxinA for Refractory Overactive Bladder (OAB) - Beyond the Abstract June 1, 2021

Racial and Socioeconomic Factors Influence Utilization of Advanced Therapies in Commercially Insured OAB Patients: An Analysis of over 800,000 OAB Patients - Beyond the Abstract September 14, 2020

Is the Addition of Vaginal Electrical Stimulation to Transcutaneous Tibial Nerve Electrical Stimulation More Effective for Overactive Bladder Treatment? a Randomized Controlled Trial - Beyond the Abstract August 21, 2020

Altered Gut Microbiome Associated with Overactive Bladder and Daily Urinary Urgency - Beyond the Abstract July 7, 2020

Aerococcus Urinae Isolated from Women with Lower Urinary Tract Symptoms: In Vitro Aggregation and Genome Analysis - Beyond the Abstract May 28, 2020

The Association Between Serum Serotonin Levels and Overactive Bladder: Results from a Community-Based Cross-Sectional Study in Japan - Beyond the Abstract April 30, 2020

New Participant Stratification and Combination of Urinary Biomarkers and Confounders Could Improve Diagnostic Accuracy for Overactive Bladder - Beyond the Abstract March 5, 2020

Racial and Ethnic Differences in Urodynamic Parameters in Women With Overactive Bladder Symptoms - Beyond the Abstract February 18, 2020

Patient Navigation for Overactive Bladder Improves Access to Care - Beyond the Abstract January 23, 2020

A Preliminary Study on the Impact of Detrusor Overactivity on the Efficacy of Selective Bladder Denervation for the Treatment of Female Refractory Overactive Bladder - Beyond the Abstract January 21, 2020

Women with Overactive Bladder Exhibit More Unhealthy Toileting Behaviors: a Cross-Sectional Study - Beyond the Abstract January 9, 2020

A Prospective Study to Evaluate Efficacy Using the Nuro™ Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients with Overactive Bladder Syndrome - Beyond the Abstract July 28, 2019

Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder - Beyond the Abstract July 12, 2019

A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment - Beyond the Abstract May 14, 2019

Abdominal versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator - Beyond the Abstract March 7, 2019

A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, Design, and Methodology– Beyond the Abstract June 11, 2018

Association Between Coronary Artery Disease Severity and Overactive Bladder in Geriatric Patients: Beyond the Abstract October 27, 2017

Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers: Beyond the Abstract October 13, 2017

What is the true catheterization rate after intravesical onabotulinumtoxinA injection: Beyond the Abstract August 23, 2017

Real-Time Changes in Brain Activity During Sacral Neuromodulation for Overactive Bladder: Beyond the Abstract July 25, 2017

Page 1 of 4